Amgen is a biopharmaceutical company that develops and manufactures drugs to treat a variety of diseases.
The company was founded in 1980 and is based in Thousand Oaks, California. Amgen has a large portfolio of drugs, including treatments for cancer, bone disease, cardiovascular disease, and inflammatory disorders.
Some of the company’s most well-known products include Enbrel (etanercept) for rheumatoid arthritis, Neulasta (pegfilgrastim) for chemotherapy-induced neutropenia, and Prolia (denosumab) for osteoporosis.
Amgen is also actively involved in research and development of new drugs and therapies, particularly in the area of biologics.